Tag Archives: Disease

Eye test may detect Alzheimer’s

A SIMPLE eye test could be the key to diagnosing the early stages of Alzheimer’s, scientists claim.

Sufferers might now be pinpointed well in advance of the destruction caused by the killer brain disease.

And this latest finding will give experts a better chance of keeping the crippling illness at bay for longer.

Researchers are hailing the quick and easy test because Alzheimer’s is an incurable condition and experts believe the key to tackling it – and stopping it – lies in early detection.

People could eventually be screened for dementia in much the same way they are for a range of cancers and other chronic illnesses.

At least 850,000 people in Britain have dementia with more than half suffering from Alzheimer’s. The figure is expected to soar by 1.7 million within the next 40 years as the population ages.

Research led by Lancaster University – in partnership with Royal Preston Hospital, Lancashire Teaching Hospitals NHS foundation trust – has shown that people with Alzheimer’s have difficulty with one particular type of eye tracking test.

As part of the team’s study, 18 patients with Alzheimer’s, 25 patients with Parkinson’s, 17 healthy young people and 18 healthy older people were asked to follow the movements of light on a computer. But in some instances they were asked to look away from the light.

Detailed eye-tracking measurements taken from the group showed stark contrasts in results.

Patients with Alzheimer’s made errors when they were asked to look away from the light and were unable to correct those errors.

This was despite them being able to respond perfectly normally when asked to look towards the light.

Alzheimer’s

Alzheimer’s

These errors were 10 times more frequent in the Alzheimer’s patients compared with the control groups.

Researchers, whose study is published in the Journal of the American Ageing Association, also measured memory function among Alzheimer’s patients who found the test difficult.

This revealed a clear correlation with lower memory function.

Dr Trevor Crawford, of the department of Psychology and the Centre for Ageing Research at Lancaster University, said these new results were potentially very exciting as they demonstrated, for the first time, a connection with the memory impairment that is so often the first noticeable symptom in Alzheimer’s disease.

He said: “The diagnosis of Alzheimer’s disease is currently heavily dependent on the results of a series of lengthy neuropsychological tests.


“However, patients with a dementia often find that these tests are difficult to complete due to a lack of clear understanding and lapse in their attention or motivation.

“The light tracking test could play a vital role in diagnosis as it allows us to identify and exclude alternative explanations of the test results.”

Alzheimer’s disease is a devastating disorder which starts many years before the symptoms begin to appear.

A toxic protein in the brain called beta amyloid is a hallmark of the disease and can build up for more than a decade before any outward signs of dementia such as confusion or memory loss.

Dr Eric Karran, director of research at Alzheimer’s Research UK, said: “This study suggests eye-tracking tests could help to highlight memory problems in Alzheimer’s. While it is unlikely Alzheimer’s could be diagnosed by a single eye test, the findings could help expand the battery of tests currently needed for diagnosis.

“It will now be important for the potential of this visual equipment to be explored in larger groups.”

Nasal insulin may relieve Alzheimer’s symptoms

Nasal insulin spray has beneficial effect for people with Alzheimer’s.

Researchers have known for some time that insulin is important for normal brain function, and now new research suggests that boosting insulin levels could help prevent cognitive deterioration.

Following the progress of three study participant groups – one receiving 20 IU (international units) of insulin each day, another 40 IU, and the rest a placebo – researchers assessed patients’ memory recall. The groups underwent treatment for four months and the insulin was given via a nasal spray. Participants were told a story, and were asked to recall its details immediately after and then after a short time lapse. They were also scored on the Dementia Severity Rating Scale.

Alzheimer’s

Alzheimer’s

The study participants who received 20 IU of insulin each day showed better recall of the story, when compared to the placebo group. The group who got 40 IU, however, showed no improvement. In younger study participants, both insulin doses had a beneficial effect, improving both story recall and scores on the Dementia Severity Rating Scale.


These results, say the researchers, not only provide a possible treatment for improving cognitive function in those with Alzheimer’s, it could also provide a clue as to how the disease progresses, potentially helping scientists understand how to prevent or halt it.